ACM
HAE icon

Aquatic Capital Management’s Haemonetics HAE Stock Holding History

Aquatic Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,003
Closed -$1.28M – 1562
2025
Q4 		$1.28M Buy
+16,003
New +$1.08M 0.04% 486
2024
Q1 		– Sell
-27,300
Closed -$2.33M – 1387
2023
Q4 		$2.33M Buy
+27,300
New +$2.36M 0.06% 297
2023
Q3 		– Sell
-9,600
Closed -$817K – 1407
2023
Q2 		$817K Buy
+9,600
New +$812K 0.04% 350
2023
Q1 		– Sell
-18,000
Closed -$1.42M – 1461
2022
Q4 		$1.42M Buy
18,000
+11,900
+195% +$956K 0.1% 244
2022
Q3 		$452K Buy
+6,100
New +$438K 0.04% 433
2022
Q2 		– Sell
-100
Closed -$6K – 1347
2022
Q1 		$6K Sell
100
-100
-50% -$5.44K 0.01% 791
2021
Q4 		$11K Buy
+200
New +$12.2K 0.02% 768

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aquatic Capital Management's HAE Position: Q1 2026 in Review

Aquatic Capital Management sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 16,003 shares — an estimated $1.28M sold.

Aquatic Capital Management first reported a position in HAE in Q4 2021 and held it in 7 quarters. The position peaked at $2.33M in Q4 2023. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Aquatic Capital Management reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 16,003 Haemonetics shares in Q1 2026, an estimated $1.28M.
  • Aquatic Capital Management first reported a position in Haemonetics in Q4 2021 and held it in 7 quarters.
  • Aquatic Capital Management's Haemonetics position peaked at $2.33M in Q4 2023.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.